[Oral antidiabetic agents: which role in 2006?].
This article offers a review of the five classes of oral antidiabetics which are currently available, and focuses on practical considerations about the daily use of these drugs. Based on data from recent studies, it addresses several frequently asked questions. Which treatment to choose for which patient? How to adapt the treatment facing the progression of type 2 diabetes, which most often necessitates an intensification of the therapeutic means over time? Usually there are several initial therapeutic options for a given patient. The glycemic control over the following months allows to verify the efficiency of the treatment chosen. In case of a persistant glycemic imbalance, early intensification of the treatment is recommended.
Gasteyger
C
C
Service d'endocrinologie, diabétologie et métabolisme, CHUV, 1011 Lausanne. Christoph.Gasteyger@chuv.ch
Egli
M
M
D000284:Administration, Oral; D003920:Diabetes Mellitus / Q000188:drug therapy*; D006801:Humans; D007004:Hypoglycemic Agents / Q000494:pharmacology* / Q000627:therapeutic use
D007004:Hypoglycemic Agents